# Align Technology (ALGN) — Earnings

ALGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/algn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.64 |
| EPS estimate | $2.62 |
| EPS surprise | +0.91% |
| Revenue surprise | +0.40% |
| Revenue | $1.1B |
| Revenue estimate | $1.1B |
| Reported | Jul 29, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1097149/000109714926000060/algn-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/6d4cccb1-19e2-27ac-c92e-9d312af6a139.html) |

Align Technology reported Q2 2026 results on July 29, 2026. Earnings per share came in at $2.64, ahead of the $2.62 estimate by 0.91%. Revenue was $1.1 billion, in line with the $1.1 billion consensus. Compared with Q2 2025, EPS rose about 6% from $2.49, and revenue rose from $1.0 billion.

Annual EPS rose every year, from $7.22 in 2022 to $10.52 in 2025, about 46% over three years. Annual revenue moved much less, from $3.73 billion in 2022 to $3.98 billion in 2025, about 7%. The first half of 2026 adds up to $5.22, about 13% more than the $4.62 earned a year earlier. Q4 2025 holds the EPS high in the table at $3.29. The low was Q3 2022, at $1.36, which was also the largest miss here at 37.04% below the estimate. Over the last 20 quarters, Align beat the EPS estimate 14 times. Three of the six misses came in 2022.

Align reported Q3 between October 23 and October 29 in each of the past five years. That points to late October 2026 for the next report. It will show whether the year-over-year EPS growth of the first half continues.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 29, 2026 | $2.62 | $2.64 | 0.91% | $1.1B | $1.1B |
| Q1 2026 | Apr 29, 2026 | $2.30 | $2.58 | 12.40% | $1.0B | $1.0B |
| Q4 2025 | Feb 4, 2026 | $2.97 | $3.29 | 10.63% | $1.0B | $1.0B |
| Q3 2025 | Oct 29, 2025 | $2.40 | $2.61 | 8.61% | $976.4M | $995.7M |
| Q2 2025 | Jul 30, 2025 | $2.57 | $2.49 | -3.23% | $1.1B | $1.0B |
| Q1 2025 | Apr 30, 2025 | $1.99 | $2.13 | 7.22% | $975.2M | $979.3M |
| Q4 2024 | Feb 5, 2025 | $2.45 | $2.44 | -0.34% | $996.9M | $995.2M |
| Q3 2024 | Oct 23, 2024 | $2.31 | $2.35 | 1.53% | $990.0M | $977.9M |
| Q2 2024 | Jul 24, 2024 | $2.34 | $2.41 | 3.15% | $1.0B | $1.0B |
| Q1 2024 | Apr 24, 2024 | $1.97 | $2.14 | 8.57% | $974.5M | $997.4M |
| Q4 2023 | Jan 31, 2024 | $2.18 | $2.42 | 11.22% | $933.7M | $956.7M |
| Q3 2023 | Oct 25, 2023 | $2.26 | $2.14 | -5.41% | $994.5M | $960.2M |
| Q2 2023 | Jul 26, 2023 | $2.03 | $2.22 | 9.10% | $991.3M | $1.0B |
| Q1 2023 | Apr 26, 2023 | $1.69 | $1.82 | 7.69% | $903.2M | $943.1M |
| Q4 2022 | Feb 1, 2023 | $1.53 | $1.73 | 12.71% | $891.8M | $901.5M |
| Q3 2022 | Oct 26, 2022 | $2.16 | $1.36 | -37.04% | $963.8M | $890.3M |
| Q2 2022 | Jul 27, 2022 | $2.23 | $2.00 | -10.23% | $984.7M | $969.6M |
| Q1 2022 | Apr 27, 2022 | $2.30 | $2.13 | -7.20% | $1.0B | $973.2M |
| Q4 2021 | Feb 2, 2022 | $2.74 | $2.83 | 3.24% | $1.0B | $1.0B |
| Q3 2021 | Oct 27, 2021 | $2.60 | $2.87 | 10.54% | $977.8M | $1.0B |

## Frequently Asked Questions

### When did Align Technology (ALGN) last report earnings?

Align Technology last reported on Jul 29, 2026, covering fiscal Q2 2026.

### Did ALGN beat earnings estimates?

Yes. Align Technology reported EPS of $2.64 for Q2 2026 against a $2.62 estimate — a 0.91% beat.

### How much revenue did ALGN report last quarter?

Align Technology reported $1.1B in revenue for Q2 2026, against a consensus estimate of $1.1B.

## Similar Stocks

- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock
- [QTRX](https://www.lighthorse.io/tickers/qtrx) — Quanterix Corporation - Common Stock
- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [RMD](https://www.lighthorse.io/tickers/rmd) — ResMed Inc. Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).